TR201007109A2 - Tek birim dozaj formları. - Google Patents
Tek birim dozaj formları.Info
- Publication number
- TR201007109A2 TR201007109A2 TR2010/07109A TR201007109A TR201007109A2 TR 201007109 A2 TR201007109 A2 TR 201007109A2 TR 2010/07109 A TR2010/07109 A TR 2010/07109A TR 201007109 A TR201007109 A TR 201007109A TR 201007109 A2 TR201007109 A2 TR 201007109A2
- Authority
- TR
- Turkey
- Prior art keywords
- dosage forms
- single unit
- unit dosage
- donepezil
- alzheimer
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 3
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 abstract 2
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract 1
- 229960003530 donepezil Drugs 0.000 abstract 1
- 229940068052 ginkgo biloba extract Drugs 0.000 abstract 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş donepezil veya farmasötik açıdan uygun herhangi bir türevini ve ginkgo biloba özütü içeren tek birim dozaj formlarma ve bu tarz dozaj formlarının alzheimer tedavisinde kullanımına ilişkindir.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/07109A TR201007109A2 (tr) | 2010-08-25 | 2010-08-25 | Tek birim dozaj formları. |
| TR2011/08087A TR201108087A2 (tr) | 2010-08-25 | 2011-08-12 | Tek birim katı dozaj formları. |
| PCT/TR2011/000192 WO2012026904A1 (en) | 2010-08-25 | 2011-08-19 | A single unit dosage form on the basis of a combination comprising donepezil and ginkgo biloba extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/07109A TR201007109A2 (tr) | 2010-08-25 | 2010-08-25 | Tek birim dozaj formları. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201007109A2 true TR201007109A2 (tr) | 2012-03-21 |
Family
ID=44947168
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/07109A TR201007109A2 (tr) | 2010-08-25 | 2010-08-25 | Tek birim dozaj formları. |
| TR2011/08087A TR201108087A2 (tr) | 2010-08-25 | 2011-08-12 | Tek birim katı dozaj formları. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2011/08087A TR201108087A2 (tr) | 2010-08-25 | 2011-08-12 | Tek birim katı dozaj formları. |
Country Status (2)
| Country | Link |
|---|---|
| TR (2) | TR201007109A2 (tr) |
| WO (1) | WO2012026904A1 (tr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014007774A1 (en) * | 2012-07-02 | 2014-01-09 | Mahmut Bilgic | Water soluble formulations comprising a piperidine derivative active agent |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
-
2010
- 2010-08-25 TR TR2010/07109A patent/TR201007109A2/tr unknown
-
2011
- 2011-08-12 TR TR2011/08087A patent/TR201108087A2/tr unknown
- 2011-08-19 WO PCT/TR2011/000192 patent/WO2012026904A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012026904A1 (en) | 2012-03-01 |
| TR201108087A2 (tr) | 2012-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015020466A8 (pt) | inibidores de cdc7, seus usos, e composição farmacêutica | |
| MY191357A (en) | Sustained-release dosage forms of ruxolitinib | |
| MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
| MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
| TN2015000076A1 (en) | Methods of treating alzheimer's disease and pharmaceutical compositions thereof | |
| UA109650C2 (xx) | Біс-арилзв'язані арилтриазолони та їх застосування | |
| JOP20190191B1 (ar) | وحدات شجرية علاجية | |
| UA107550C2 (uk) | Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| MX2016002580A (es) | Combinacion de un inhibidor de alk y un inhibidor de cdk para el tratamiento de enfermedades celulares proliferativas. | |
| IN2012DN05186A (tr) | ||
| CL2014003325A1 (es) | Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer | |
| CL2012001940A1 (es) | Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple. | |
| CL2014003607A1 (es) | Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer. | |
| TR201007110A2 (tr) | Sinerjik etki gösteren kombinasyonlar | |
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| UA116499C2 (uk) | (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| TR201007109A2 (tr) | Tek birim dozaj formları. | |
| TR201007111A2 (tr) | Sinerjik etki gösteren bileşimler. | |
| TR201100152A2 (tr) | Amlodipin içeren efervesan bileşimler. | |
| WO2014023869A3 (es) | Aplicacion terapéutica de agentes inhibidores de cd44 frente a la leucemia linfoblástica aguda (all) humana | |
| TR200906322A2 (tr) | Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. | |
| PH12019501070A1 (en) | Sustained-release dosage forms of ruxolitinib | |
| TR201204568A2 (tr) | Galantamin içeren efervesan tablet. | |
| TR201205320A2 (tr) | Galantamin formülasyonları ve üretim yöntemi. |